Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$253.28
▼ $0.63 (−0.25%) today
Markets closed · 3:26am ET

JNJ Coverage Page 57

10:50am ET
Health and Healthcare

New Crohn’s Disease Drug Approved by FDA

A unit of Johnson & Johnson has announced that the FDA has approved its Stelara for the treatment of moderately to severely active Crohn's disease.

JNJ
Jon C. Ogg
4:01pm ET
Investing

Apple, J&J Weigh on DJIA Monday

August 22, 2016: Markets opened lower again Monday as investors remain cautious ahead of the Fed’s Jackson Hole conference beginning Thursday. Fed Chairwoman Janet Yellen is scheduled to speak on Friday and…

Paul Ausick
4:01pm ET
Investing

McDonald’s, J&J Buoy DJIA on Tuesday

July 19, 2016: Markets opened mixed on Tuesday with the blue chips opening lower before bouncing higher. Unlike the S&P 500 Index and the Nasdaq Composite, which never traded higher at any…

Paul Ausick
9:25am ET
Health and Healthcare

Johnson & Johnson Offers Q2 Earnings Beat, Rosy Guidance

As one of the largest health care companies on the market, Johnson & Johnson helps set a direction for the industry. Strength within its pharmaceutical segment helped push this company to new…

JNJ
Chris Lange
10:25am ET
Health and Healthcare

What to Look for in Johnson & Johnson Earnings

Johnson & Johnson is set to release its second-quarter earnings report before the markets open on Tuesday, a period in which it agreed to acquire a privately held company focused on hair…

JNJ
Chris Lange
10:15am ET
Investing

Top Dow Earnings for the Week Ahead

One-third of the 30 Dow stocks are reporting quarterly results between July 18 and 22. The main question is whether these earnings can push the Dow to new highs.

Chris Lange